Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Current Taxes (2021 - 2022)

Historic Current Taxes for Cartesian Therapeutics (RNAC) over the last 2 years, with Q2 2022 value amounting to $320000.0.

  • Cartesian Therapeutics' Current Taxes changed N/A to $320000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $320000.0, marking a year-over-year change of. This contributed to the annual value of $601000.0 for FY2021, which is N/A changed from last year.
  • Cartesian Therapeutics' Current Taxes amounted to $320000.0 in Q2 2022.
  • Over the past 5 years, Cartesian Therapeutics' Current Taxes peaked at $15.8 million during Q3 2021, and registered a low of $320000.0 during Q1 2022.